An explainable AI approach for mapping multivariate regional brain age and clinical severity patterns in Alzheimer’s disease
Age is a significant risk factor for mild cognitive impairment (MCI) and Alzheimer's disease (AD) and identifying brain age patterns is critical for comprehending the normal aging and MCI/AD processes. Prior studies have widely established the univariate relationships between brain regions and age, while multivariate associations remain largely unexplored. Herein, various artificial intelligence (AI) models were used to perform brain age prediction using an MRI dataset (<i>n</i> = 825). The optimal AI model was then integrated with the feature importance methods, namely Shapley additive explanations (SHAP), local interpretable model-agnostic explanations, and layer-wise relevance propagation, to identify the significant multivariate brain regions hierarchically involved in this prediction. Our results showed that the deep learning model (referred to as AgeNet) outperformed conventional machine learning models for brain age prediction, and that AgeNet integrated with SHAP (referred to as AgeNet-SHAP) identified all ground-truth perturbed regions as key predictors of brain age in semi-simulation, demonstrating the validity of our methodology. In the experimental dataset, when compared to cognitively normal (CN) participants, MCI exhibited moderate differences in brain regions, whereas AD showed highly robust and widely distributed regional differences. Individualized AgeNet-SHAP regional features further showed associations with clinical severity scores in the AD continuum. These results collectively facilitate data-driven explainable AI approaches for disease progression, diagnostics, prognostics, and personalized medicine efforts.
Authors
- Taslim Murad (ORCID: https://orcid.org/0000-0001-6434-3297)
- Ganesh B. Chand (ORCID: https://orcid.org/0000-0002-9857-5800)
- Deepa S. Thakuri
- Hui-Yuan Miao (ORCID: https://orcid.org/0009-0007-4127-4146)
- Gauri Darekar
Institutions
- Washington University in St. Louis (US)
- Mallinckrodt (United States) (US)
- Alzheimer’s Disease Neuroimaging Initiative (US)
- Hope Center for Neurological Disorders (US)
- University of Missouri (US)
Publication Details
- Journal
- Biology Methods and Protocols
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/biomethods/bpaf051
- Primary Topic
- Machine Learning in Healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- Alzheimer's Association
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Biogen
- Meso Scale Diagnostics
- Washington University in St. Louis
- BioClinica
- Novartis Pharmaceuticals Corporation
- Eisai
- Servier
- H. Lundbeck A/S
- IXICO
- National Institutes of Health
- Genentech
- Canadian Institutes of Health Research